抗病毒-话题@MedSci

#抗病毒#

311篇内容 | 5734人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1292415, encodeId=d7661292415b8, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Lancet Infect Dis:新型直接抗病毒药物用于毒品注射人群的丙肝预防是否有效？, objectType=article, longId=131618, objectId=0db113161815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0db113161815, replyNumber=0, likeNumber=64, createdTime=2018-03-08, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0db113161815, moduleTitle=Lancet Infect Dis:新型直接抗病毒药物用于毒品注射人群的丙肝预防是否有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0db113161815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292414, encodeId=6993129241473, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Hepatology：直接抗病毒药物并没有增加局部区域治疗或肝移植候补患者的肝细胞癌复发的风险, objectType=article, longId=130743, objectId=054e130e4370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=054e130e4370, replyNumber=0, likeNumber=0, createdTime=2018-02-28, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=054e130e4370, moduleTitle=Hepatology：直接抗病毒药物并没有增加局部区域治疗或肝移植候补患者的肝细胞癌复发的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=054e130e4370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292413, encodeId=1a2b12924137e, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Viral Hepat：相比其他抗病毒药物，恩替卡韦和替诺福韦更有效地减少乙肝病毒相关的肝细胞癌复发, objectType=article, longId=129398, objectId=580b129398c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=580b129398c2, replyNumber=0, likeNumber=58, createdTime=2018-02-10, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=580b129398c2, moduleTitle=J Viral Hepat：相比其他抗病毒药物，恩替卡韦和替诺福韦更有效地减少乙肝病毒相关的肝细胞癌复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=580b129398c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292412, encodeId=50a91292412c0, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Exp Med：胃癌发生过程中抗病毒通路与Hippo-YAP通路互作的分子机制, objectType=article, longId=128352, objectId=e5ee128352f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5ee128352f6, replyNumber=0, likeNumber=60, createdTime=2018-02-01, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5ee128352f6, moduleTitle=J Exp Med：胃癌发生过程中抗病毒通路与Hippo-YAP通路互作的分子机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5ee128352f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292411, encodeId=27f212924116a, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Cell：天然杀手T细胞在启动B细胞抗病毒免疫反应中的作用, objectType=article, longId=128139, objectId=c2c0128139f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2c0128139f9, replyNumber=0, likeNumber=53, createdTime=2018-01-31, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2c0128139f9, moduleTitle=Cell：天然杀手T细胞在启动B细胞抗病毒免疫反应中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2c0128139f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292410, encodeId=3a2e12924109a, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Hepatol：在资源有限的情况下，直接抗病毒药物治疗HCV患者的经验及教训, objectType=article, longId=128000, objectId=4355128000b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4355128000b8, replyNumber=0, likeNumber=58, createdTime=2018-01-29, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4355128000b8, moduleTitle=J Hepatol：在资源有限的情况下，直接抗病毒药物治疗HCV患者的经验及教训, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4355128000b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292409, encodeId=90d9129240941, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益, objectType=article, longId=127902, objectId=f5aa12e90269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5aa12e90269, replyNumber=0, likeNumber=77, createdTime=2018-01-28, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5aa12e90269, moduleTitle=J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5aa12e90269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292408, encodeId=bcf7129240837, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=“不打针爷爷”胡皓夫逝世：坐诊几十年只开抗病毒西药和中药, objectType=article, longId=127896, objectId=384e12e8965f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=384e12e8965f, replyNumber=0, likeNumber=61, createdTime=2018-01-28, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=384e12e8965f, moduleTitle=“不打针爷爷”胡皓夫逝世：坐诊几十年只开抗病毒西药和中药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=384e12e8965f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292407, encodeId=f25c129240eb5, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Lancet Infect Dis：流感：奥司他韦联合抗病毒治疗比单药临床获益更多？, objectType=article, longId=127810, objectId=b97612e810f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b97612e810f8, replyNumber=0, likeNumber=61, createdTime=2018-01-28, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b97612e810f8, moduleTitle=Lancet Infect Dis：流感：奥司他韦联合抗病毒治疗比单药临床获益更多？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b97612e810f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292406, encodeId=c689129240646, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=Lancet Gastroen Hepatol：HCV抗病毒治疗过程中的HBV再激活风险, objectType=article, longId=127564, objectId=bc6c12e56400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc6c12e56400, replyNumber=0, likeNumber=52, createdTime=2018-01-26, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc6c12e56400, moduleTitle=Lancet Gastroen Hepatol：HCV抗病毒治疗过程中的HBV再激活风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc6c12e56400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292405, encodeId=a77f129240546, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Gastroenterol Hepatol：乙肝表面抗原的整合对抗病毒治疗患者HBsAg水平的影响, objectType=article, longId=127473, objectId=3cb212e47384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cb212e47384, replyNumber=0, likeNumber=60, createdTime=2018-01-25, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cb212e47384, moduleTitle=J Gastroenterol Hepatol：乙肝表面抗原的整合对抗病毒治疗患者HBsAg水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cb212e47384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292404, encodeId=321f12924043e, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Viral Hepat：波兰HCV患者经直接抗病毒药物治疗的疗效和安全性, objectType=article, longId=127298, objectId=ff0b12e2981c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0b12e2981c, replyNumber=0, likeNumber=61, createdTime=2018-01-24, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0b12e2981c, moduleTitle=J Viral Hepat：波兰HCV患者经直接抗病毒药物治疗的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0b12e2981c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292403, encodeId=16e21292403c3, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=国家卫计委：我国抗病毒药物供应保障充足, objectType=article, longId=127189, objectId=30ec12e18959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30ec12e18959, replyNumber=0, likeNumber=59, createdTime=2018-01-23, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30ec12e18959, moduleTitle=国家卫计委：我国抗病毒药物供应保障充足, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30ec12e18959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292402, encodeId=369112924028b, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Hepatol：等待肝移植期间接受抗病毒治疗的患者的临床结局, objectType=article, longId=125810, objectId=ac0d125810f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0d125810f4, replyNumber=0, likeNumber=62, createdTime=2018-01-08, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0d125810f4, moduleTitle=J Hepatol：等待肝移植期间接受抗病毒治疗的患者的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac0d125810f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292401, encodeId=08b91292401b8, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=PLOS Pathog：发现一种抗病毒蛋白可能阻止黑猩猩传播HIV前体, objectType=article, longId=124372, objectId=4dd51243e25c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dd51243e25c, replyNumber=0, likeNumber=18, createdTime=2017-12-24, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dd51243e25c, moduleTitle=PLOS Pathog：发现一种抗病毒蛋白可能阻止黑猩猩传播HIV前体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dd51243e25c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292400, encodeId=2966129240096, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Cell Mol Med：肝组织免疫组织化学检测HBcAg(-)是抗病毒治疗的预测指标, objectType=article, longId=122583, objectId=10dc122583e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10dc122583e8, replyNumber=0, likeNumber=0, createdTime=2017-12-08, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10dc122583e8, moduleTitle=J Cell Mol Med：肝组织免疫组织化学检测HBcAg(-)是抗病毒治疗的预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10dc122583e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292399, encodeId=6cfa1292399c2, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Viral Hepat：肝炎暴发的患者，在抗病毒治疗早期HBsAg快速下降且下降幅度较大, objectType=article, longId=122445, objectId=ee5c12244584, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee5c12244584, replyNumber=0, likeNumber=62, createdTime=2017-12-07, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee5c12244584, moduleTitle=J Viral Hepat：肝炎暴发的患者，在抗病毒治疗早期HBsAg快速下降且下降幅度较大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee5c12244584)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292398, encodeId=613f1292398b8, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率, objectType=article, longId=122123, objectId=30d7122123c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30d7122123c6, replyNumber=0, likeNumber=67, createdTime=2017-12-04, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30d7122123c6, moduleTitle=J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30d7122123c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292397, encodeId=971f129239e25, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=吉利德覆盖慢性丙型肝炎泛基因型的口服抗病毒药物索华迪®（通用名：索磷布韦）在华上市, objectType=article, longId=121574, objectId=f1be1215e46b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1be1215e46b, replyNumber=0, likeNumber=80, createdTime=2017-11-29, rootId=0, userName=yahu, userId=52c7237, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1be1215e46b, moduleTitle=吉利德覆盖慢性丙型肝炎泛基因型的口服抗病毒药物索华迪®（通用名：索磷布韦）在华上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1be1215e46b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292396, encodeId=23811292396c3, content=<a href='/topic/show?id=a3b4554e19d' target=_blank style='color:#2F92EE;'>#抗病毒#</a>, objectTitle=J Viral Hepat：直接抗病毒治疗，丙型肝炎病毒根除后，肝外淋巴结肿大消失, objectType=article, longId=121510, objectId=77f61215100a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77f61215100a, replyNumber=0, likeNumber=58, createdTime=2017-11-28, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77f61215100a, moduleTitle=J Viral Hepat：直接抗病毒治疗，丙型肝炎病毒根除后，肝外淋巴结肿大消失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77f61215100a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗病毒

2020-05-29

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Lancet Infect Dis:新型直接抗病毒药物用于毒品注射人群的丙肝预防是否有效？

2018-03-08

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Hepatology：直接抗病毒药物并没有增加局部区域治疗或肝移植候补患者的肝细胞癌复发的风险

2018-02-28

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Viral Hepat：相比其他抗病毒药物，恩替卡韦和替诺福韦更有效地减少乙肝病毒相关的肝细胞癌复发

2018-02-10

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Exp Med：胃癌发生过程中抗病毒通路与Hippo-YAP通路互作的分子机制

2018-02-01

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Cell：天然杀手T细胞在启动B细胞抗病毒免疫反应中的作用

2018-01-31

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Hepatol：在资源有限的情况下，直接抗病毒药物治疗HCV患者的经验及教训

2018-01-29

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益

2018-01-28

yahu (审核中...)

前往app查看评论内容

#抗病毒#

“不打针爷爷”胡皓夫逝世：坐诊几十年只开抗病毒西药和中药

2018-01-28

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Lancet Infect Dis：流感：奥司他韦联合抗病毒治疗比单药临床获益更多？

2018-01-28

yahu (审核中...)

前往app查看评论内容

#抗病毒#

Lancet Gastroen Hepatol：HCV抗病毒治疗过程中的HBV再激活风险

2018-01-26

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Gastroenterol Hepatol：乙肝表面抗原的整合对抗病毒治疗患者HBsAg水平的影响

2018-01-25

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Viral Hepat：波兰HCV患者经直接抗病毒药物治疗的疗效和安全性

2018-01-24

yahu (审核中...)

前往app查看评论内容

#抗病毒#

国家卫计委：我国抗病毒药物供应保障充足

2018-01-23

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Hepatol：等待肝移植期间接受抗病毒治疗的患者的临床结局

2018-01-08

yahu (审核中...)

前往app查看评论内容

#抗病毒#

PLOS Pathog：发现一种抗病毒蛋白可能阻止黑猩猩传播HIV前体

2017-12-24

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Cell Mol Med：肝组织免疫组织化学检测HBcAg(-)是抗病毒治疗的预测指标

2017-12-08

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Viral Hepat：肝炎暴发的患者，在抗病毒治疗早期HBsAg快速下降且下降幅度较大

2017-12-07

yahu (审核中...)

前往app查看评论内容

#抗病毒#

J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率

2017-12-04

yahu (审核中...)

前往app查看评论内容

#抗病毒#

吉利德覆盖慢性丙型肝炎泛基因型的口服抗病毒药物索华迪®（通用名：索磷布韦）在华上市

2017-11-29

智者为医08 (审核中...)

前往app查看评论内容

#抗病毒#

J Viral Hepat：直接抗病毒治疗，丙型肝炎病毒根除后，肝外淋巴结肿大消失

2017-11-28

科室
- - 订阅+
  - 更多科室
工具
服务